Hisanori Taniguchi
Overview
Explore the profile of Hisanori Taniguchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
245
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Taniguchi H, Ikeda J, Masuo Y, Kinoshita H
Jpn J Clin Oncol
. 2025 Feb;
PMID: 39987487
Objective: Cabazitaxel (CAZ) has been shown to prolong overall survival (OS) in patients with metastatic castration-resistant prostate cancer (mCRPC) following docetaxel treatment. However, the impact of the number of prior...
2.
Taniguchi H, Shimada S, Kinoshita H, Matsuda T
Hinyokika Kiyo
. 2024 Nov;
70(7):207-211.
PMID: 39592454
The clinical practice manual for late-onset hypogonadism (LOH) was updated in 2022. This study analyzed the total and free testosterone levels of patients who visited our specialized hypogonadism outpatient clinic...
3.
Ikeda J, Taniguchi H, Takayama H, Masuo Y, Nakamoto T, Uchida K, et al.
IJU Case Rep
. 2024 Nov;
7(6):459-462.
PMID: 39498180
Introduction: Neuroendocrine prostate cancer is an aggressive histological subtype of prostate cancer with a poor prognosis. Neuroendocrine prostate cancer is traditionally treated with cisplatin-based chemotherapy, similar to that used in...
4.
Fujita K, Matsushita Y, Toyoda S, Kojima T, Yamashita S, Taniguchi H, et al.
World J Urol
. 2024 Sep;
42(1):536.
PMID: 39325218
Purpose: Metastatic non-clear cell renal cell carcinoma (nccRCC) is a heterogeneous disease with a poor prognosis and is treated with immunotherapy (IO)-based combinations according to the clear cell renal cell...
5.
Taniguchi H, Takizawa N, Kinoshita H
Sci Rep
. 2024 Sep;
14(1):20332.
PMID: 39223151
To demonstrate the prevalence and risk factors for overactive bladder symptoms associated with artificial urinary sphincter implantation, we investigated the patients who underwent primary artificial urinary sphincter implantation with severe...
6.
Ohsugi H, Ikeda J, Takayasu K, Takizawa N, Taniguchi H, Yanishi M, et al.
Int J Urol
. 2024 Jul;
31(10):1108-1113.
PMID: 39073237
Objective: We analyzed robotic partial nephrectomy (RPN) outcomes in obese patients based on body mass index (BMI) and trifecta achievement. Methods: We retrospectively reviewed 296 patients who underwent RPN at...
7.
Takeshima T, Ando S, Iwahata T, Umemoto Y, Kato M, Kobayashi H, et al.
Nihon Hinyokika Gakkai Zasshi
. 2024 Jul;
114(3):75-80.
PMID: 39034118
(Introduction) Beginning in April of 2022, infertility services-including assisted reproductive technologies and examinations and treatments for male infertility-were covered by health insurance in Japan. Although these changes are expected to...
8.
Sano T, Yoshida T, Nakamoto T, Ohe C, Taniguchi H, Yanishi M, et al.
World J Urol
. 2024 Jul;
42(1):389.
PMID: 38985343
Purpose: To compare the diagnostic performance of photodynamic diagnosis (PDD) enhanced with oral 5-aminolaevulinic acid between the suspected upper tract urothelial carcinoma (UTUC) and bladder urothelial carcinoma (BUC) cases. Methods:...
9.
Tomida R, Takahashi M, Matsushita Y, Kojima T, Yamana K, Kandori S, et al.
Clin Genitourin Cancer
. 2024 May;
22(3):102094.
PMID: 38714434
Background: To date, no studies have compared the treatment outcomes of second-line therapies in patients with metastatic clear cell renal cell carcinoma (ccRCC). This study retrospectively evaluated the efficacy of...
10.
Rambhatla A, Shah R, Ziouziou I, Kothari P, Salvio G, Gul M, et al.
World J Mens Health
. 2024 Apr;
43(1):92-122.
PMID: 38606867
Purpose: Non-obstructive azoospermia (NOA) is a common, but complex problem, with multiple therapeutic options and a lack of clear guidelines. Hence, there is considerable controversy and marked variation in the...